You must be logged in to post a comment.
The “Nonproprietary Naming of Biological Products” draft guidance was published by the Food and Drug Administration (FDA) in August 2015 […]
The Brazilian regulatory Agency, Anvisa (Agência Nacional de Vigilância Sanitária) issues market authorizations for medical devices and pharmaceuticals; exercises post-marketing […]
Developing a new pharmaceutical brand name can be a complex process, particularly in Japan where there are unique guidelines and […]
What makes a great brand name? That depends on who you ask. One thing is for certain, whether developing a […]
